Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"Renaissance has mainly quants and technical traders. Makes me wonder what they see."
Same goes for Virtu Financial which an HFT.... which just sold out 100% if ADXS yesterday after barely holding it for like a week....
Maybe the short hedgies and HFTs are covering? Let's see how the next short interest report looks like
Also, ADXS is a clear threat to Roche's Avastin ($7 billion per year) based on phase 2 results...
Could Roche be suppressing ADXS from the profits of Avastin?
Here's a thought:
If big corporations can sell very long duration bonds at 3%.... why can't ADXS sell very long duration bonds at 9%?
Thanks would kill all of the shorties on the spot and we fly to $30s for sure
Virtu Financial just closed out its position in ADXS today... completely out....
Some folks here were liking Virtu Financial holding ADXS, but I personally didn't like a HFT holding ADXS shares.. good riddance
Where do you see 111 sites? I can see the counties, but I am unable to find the total number of sites.
Could it be that ADAGE strategically went just below 10% to bypass some reporting requirements?
So from 11/14/17 to today... ADAGE dumped another 700k shares and is now about 9.8% owner...
2017-11-14 13F-HR Adage Capital Partners GP LLC 5,939,366 4,700,043 -20.87
Agreed. AT-014 and now EU a very positive commercialization progress....
The only sad part is that there are other biotechs that fly on irrelevant news... ADXS gets no love from the market no matter what...
Someone is trying to suppress ADXS PPS for sure... and ADXS Management needs to thwart that multi-year suppression... if they can't, hire an expert
Link please? I don't see it on fintel
"Is there any Phase 3 company with EMA submission has market cap of 115 million?"
You forgot to add AT-014.. a proof that ADXS LM platform works and is already in the market for dogs.
Also would like to add that Phase 3 trail has SPA and Orphan Drug designations from FDA...
Also would like to add ADXS is in Immuno-Oncology trials which should get higher valuations than regular biotech because cancer treatment = higher premium $$$
ADXS short interest:
1/31/2018 7,690,014
1/12/2018 8,236,371
12/29/2017 7,485,019
12/15/2017 7,280,448
11/30/2017 7,982,050
11/15/2017 7,579,423
"If the large deal comes for EU and other areas I think we can forget about a buy out."
The news from today does mention that ADXS is exploring an EU Partnership....
Good job williamjay, and thanks for the post.
Forget the price action... where is the F-in volume? No new buying interest today....
There are other biotechs that fart a news and their price jumps....
Then there is ADXS... no further comment needed LOL
ADXS-DUAL = no money and no commitment from BMY....
Just like ADXS-PSA = no money and no commitment from MRK....
So any change to existing nomenclature could be a positive sign... enough with these freeloaders
I just got ADXS voting packet in mail... I'm afraid to open it lol maybe over the weekend
I think a lot of folks would be ok with ADXS diluting at its FAIR stock value of twenties or at the very least teens....
Personally, I would hate to see any dilution in single digits...
"Today's PR concerns me insofar as it's the kind of action that sometimes precedes a financing transaction."
Perhaps a partnership financial transaction instead of a dilution financial transaction?
This is amazing, when you google "sell this beech", first link is our ADXS Message Board... LMAO
https://www.google.com/search?q=%22sell%20this%20beech%22&ie=utf-8&oe=utf-8
IMO, it is safe to assume that whatever is being thought up on this board, ADXS Management is not doing for sure... especially trying to "SELL THIS BEECH" LOL
TC, can you please ask your secret financial advisor the following question?
Does ADXS has anything "New" to post? From like when Tony took over and ADXS starting burning cash on hand like there's no tomorrow?
Girlfriend, I think TC's German Shepard is his secret financial adviser.
"Unfortunately I've owned a few of these stocks where they blow smoke up your butt to the last minute, until the pr of bankruptcy."
Bankruptcy on what? How can you go bankrupt on $0 debt?
"what do both of our stocks have that is so awful compared to other spec bios?"
The LM platform.... someone wants it buried
Isn't AVXL down cuz there was no update on like three trails for 2018?
How much you paid for July calls? Cheapest I could get last week was $0.35 per $5 call
Nothing new in that... I think someone did point it out on this board cuz I have seen it already
With Markets at all time highs, reduced corporate taxes, overseas money coming in..... Even a dummy could raise more money.
Let's see if ADXS Management has an IQ greater than a dummy.... so far the dummy is winning
Girlfriend... with low ADXS average, you have lived up to the stereotype that women are better investors than men LOL
Nice, just curious, how many years have you been invested in ADXS....
I found ADXS in the $20s :(
There is one problem with your plan.... when ADXS will fly, we may not even see an 8 or a 10 ;) it could gap up to double digits...
I request that this Obi's post go to sticky... it will bring us good luck and we can humorously give credit to ADXS in the future!
Girlfriend.... your name is Jane?
IMO Partnerships are more likely than a BO.... that has always been ADXS strategy reported to SEC every quarter.
When TL took over, ADXS ill used to no major strategy changes (I remember reading it) besides the 4 franchises.
EU Partnership with upfront cash and EU Submission would be more beneficial to ADXS shareholders than a buyout IMO
That part was discussed in the Q&A portion of the conference call.
ADXS 10K from Tony 12/21/17
EU Submission:
Progress to date towards submission of the filing includes axalimogene filolisbac’s designation as an ATMP, certification of quality and non-clinical data by the CAT, CHMP confirmation of eligibility for Union Marketing Authorization, assignment of EU rapporteurs, and pre-submission meetings held with the rapporteurs. Feedback from the rapporteurs advising the provision of additional clinical information in the submission package led to a delay of the filing which is now planned for Q1 2018. Once the package is submitted, the CHMP review process is expected to take approximately 13 months, and the Company plans to provide an update at the end of the review.
"Tony has been working on something the entire time."
Yes, Tony has been collecting the pay and free shares for retirement the entire time.... that's something isn't it?
"And just as important Lombardo has not lied to shareholders or done anything ethically questionable"
December 2017 Conference Call:
Tony Lombardo stated that they were ready to file for EU Submission but EU closed for holidays.... BIG A$$ LIE
""...executing high quality global submissions within required timeframes and is the principal point-of-contact with electronic submission vendor for all initial and lifecycle management filings, submitted electronically to the Health Authorities.""
I sure hope BOD didn't just wake and said "oh sh*t, we need to hire someone for EU Submission after a full year of doing nothing"
"Cmon Advaxis....get into the bitcoin dealio"
I bet just our thinking about ADXS and bitcoin at same time caused bitcoin to crash... just imagine the disaster to bitcoin when ADXS and Bitcoin name is official.... LOL
"Difference between 2.75 and 2.2.5 is 18% which could make a huge difference to your DCA depending on how much you already hold and how much you're buying."
When the average is in low double digits or high single digits.... $3 makes just as much of the impact